iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, February 28.

Monday, February 28th at 4:30 PM ET

Domestic:	877-407-0784
International:	201-689-8560
Conference ID:	13726987
Webcast:	https://themediaframe.com/mediaframe/webcast.html?webcastid=ELUrpENc

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com